Emodin Alleviates Sodium Taurocholate–Induced Pancreatic Ductal Cell Damage by Inhibiting the S100A9/VNN1 Signaling Pathway

Conclusions Emodin attenuates STC-induced pancreatic ductal cell injury possibly by inhibiting S100A9/VNN1-mediated ROS release. This finding provides evidence for the future development of emodin as a therapeutic agent.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research